Concepedia

Hongqiang Li

HL

Statistics

Publications

31

Citations

869

H-Index

18

Active since

2013

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Shanghai East Hospital

Tongji University

Shanghai Tenth People's Hospital

Henan Cancer Hospital

Hongqiang Li is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2013–2024

31

Publications

31

M2A and M2C Macrophage Subsets Ameliorate Inflammation and Fibroproliferation in Acute Lung Injury Through Interleukin 10 Pathway

Lunxian Tang, Hua Zhang, Chunmei Wang et al. · Shock · 2016 · 88 citations

, , +17

MiR‐139‐5p is associated with poor prognosis and regulates glycolysis by repressing <scp>PKM</scp> 2 in gallbladder carcinoma

Jianan Chen, Yan Yu, Xiaolong Chen et al. · Cell Proliferation · 2018 · 77 citations · Full text

, , +17

Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms

Chunmei Wang, Chen Dai, Zhongqian Hu et al. · Nanoscale Horizons · 2018 · 72 citations

, , +17

Lycium barbarum polysaccharide reduces hyperoxic acute lung injury in mice through Nrf2 pathway

Guizhen Zheng, Huijuan Ren, Hongqiang Li et al. · Biomedicine & Pharmacotherapy · 2019 · 52 citations · Full text

, , +17

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

Weiwei Zhu, Hongqiang Li, Yu Yan et al. · Cancer Management and Research · 2018 · 45 citations · Full text

, , +17

1–5 of 31